Summary
We have investigated the expression of the ectoenzyme dipeptidylpeptidase IV (DPP IV)/CD26 on lymphocytes obtained from patients with B chronic lymphocytic leukaemia (B-CLL) and compared it with healthy subjects. Using two-colour immunofluorescence analysis with CD26 and CD20 or CD23 monoclonal antibodies, CD26 was found undetectable on peripheral resting B-cells (CD20+ CD23–) from normal donors whereas it was expressed on B-cells activated in vitro with interleukin (IL)-4 and Staphylococcus aureus strain cowan I (CD20+ CD23+). The expression of CD26 on leukaemic B-cells (CD20+ CD23+) was clearly induced in 22 out of 25 patients examined. Consequently, induced levels of CD26 cell surface expression on either normal activated and malignant B-cells coincided with the enhancement of DPP IV activity detected on the surface of these cells. Reverse transcription polymerase chain reaction analyses showed that the transcript levels of the CD26 gene was higher in normal activated B-cells and B-CLL cells than in resting B-cells, suggesting that CD26 was expressed at the level of transcriptional activation. These observations provide evidence of the abnormal expression of DPPIV/CD26 in B-CLL which, therefore, may be considered as a novel marker for B-CLL. Further investigation in relation to CD26 expression and other B malignancies needs to be defined.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Abbott, C. A., Baker, E., Sutherland, G. R. & McCaughan, G. W. (1994). Genomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) gene. Immunogenetics 40: 331–338.
Andrews, C., Crockard, A. D., San Miguel, J. F. & Catovsky, D. (1985). Dipeptidylaminopeptidase IV (DAPIV) in B- and T-leukemias. Clin Lab Haematol 7: 359–368.
Bauvois, B. (1997). Molecular and functional aspects of human myelomonocytic ectopeptidases. In Cell Surface Peptidases in Health and Disease, Kenny AJ and Boustead CM (eds), pp. 341–350, Bios Ltd: Oxford
Bauvois, B., Sancéau, J. & Wietzerbin, J. (1992). Human U937 cell surface peptidase activities: characterization and degradative effect on tumour necrosis factor-α. Eur J Immunol 22: 923–930.
Bauvois, B., Van Weyenbergh, J., Rouillard, D. & Wietzerbin, J. (1996). TGF-β1-stimulated adhesion of human mononuclear phagocytes to fibronectin and laminin is abolished by IFN-γ: dependence on α5β1 and β2 integrins. Exp Cell Res 222: 209–217.
Bühling, F., Junker, U., Reinhold, D., Neubert, K., Jäger, L. & Ansorge, S. (1994). Functional role of CD26 on human B lymphocytes. Immunol Lett 45: 47–51.
Bylinkina, V. S., Lokshina, L. A., Samojlova, R. S., Lubkova, O. N., Gureeva, T. A. & Golubeva, N. V. (1992). Dipeptidylpeptidase IV in human leukemic B- and T-cells. Biochem Int 28: 31–39.
Carbone, A., Cozzi, M., Gloghini, A. & Pinto, A. (1994). CD26/dipeptidylpeptidase IV expression in human lymphomas is restricted to CD30-positive anaplastic large cells and a subset of T-cell non Hodgkin’s lymphomas. Hum Pathol 25: 1360–1365.
Chomeczynski, P. & Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156–159.
De Meester, I., Scharpé, S., Vanham, G., Bosmans, E., Heylingen, H., Vanhoof, G. & Corte, G. (1993). Antibody binding profile of purified and cell-bound CD26. Designation of BT5/9 and TA5.9 to the CD26 cluster. Immunobiology 188: 145–158.
De Meester, I., Korom, S., Belyaev, A., Stadlbauer, T., Goossens, F., Haemers, A., Kupiec-Weglinski, J. W. & Scharpé, S. (1997). Inhibition of DPPIV/CD26 enzymatic activity abrogates accelerated rejection of rat cardiac allografts. Immunol Lett 56: 487–491.
Duke-Cohan, J. S., Morimoto, C., Rocker, J. A. & Schlossman, S. F. (1996). Serum high molecular weight dipeptidyl peptidase IV (CD26) is similar to a novel antigen DPPT-L released from activated T cells. J Immunol 156: 1714–1721.
Eguchi, K., Ueki, Y., Shimomura, C., Otsubo, T., Nakao, H., Migita, K., Kawakami, A., Matsunaga, M., Tezuka, H., Ishikawaw, N., Ito, K. & Nagataki, S. (1989). Increment in the Ta1+ cells in the peripheral blood and thyroid tissue of patients with Grave’s disease. J Immunol 142: 4233–4240.
Feller, A. C., Parwaresch, R. & Lennert, K. (1983). Subtyping of chronic lymphocytic leukemia of T-type by dipeptidylpeptidase IV (DAP IV), monoclonal antibodies and Fc-receptors. Cancer 52: 1609–1612.
Fleisher, B. (1994). CD26: a surface protease involved in T-cell activation. Immunol Today 15: 180–184.
Flentke, G. R., Munoz, E., Huber, T. B., Plaut, A. G., Kettner, C. A. & Bachovchin, W. W. (1991). Inhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T-cell function. Proc Natl Acad Sci USA 88: 1556–1559.
Hafler, D. A., Fox, D. A., Manning, M. E., Schlossman, S. F., Reinherz, E. L. & Weiner, H. L. (1985). In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. New Engl J Med 312: 1405–14011.
Hegen, M., Kameoka, J., Dong, R. P., Schlossman, S. F. & Morimoto, C. (1997). Cross-linking of CD26 by antibody induces tyrosine phosphorylation and activation of mitogen-activated protein kinase. Immunology 90: 257–264.
Invernizzi, R., Bertolino, G., Girino, M., Perseghin, P., Michiensi, M. & Nano, R. (1985). Cytochemistry of dipeptidylpeptidase IV and II in normal and neoplastic lymphoid cells. Blut 50: 277–283.
Jacotot, E., Callebaut, C., Blanco, J., Krust, B., Neubert, K., Barth, A. & Hovanessian, A. (1996). Dipeptidylpeptidase IV-β, a novel form of cell surface expressed protein with dipeptidyl-peptidase IV activity. Eur J Biochem 239: 248–258.
Khalaf, M. R., Aqel, N. M. & Hayhoe, F. G. J. (1987). Histochemistry of dipeptidylaminopeptidase (DAP) II and IV in reactive lymphoid tissues and malignant lymphoma. J Clin Pathol 40: 480–485.
Kolb, J. P., Genot, E., Poggioli, J., Abadie, A., Sarfati, M., Delespesse, G. & Dugas, B. (1991). Transduction through CD23: different signalling pathways in human B cells and monocytes. Monogr Allergy 29: 135–141.
Kondo, S., Kotani, T., Tamura, K., Aratake, Y., Uno, H., Tsubuchi, H., Inoue, S., Niho, Y. & Ohtaki, S. (1996). Expression of CD26/dipeptidylpeptidase IV in adult T cell leukemia/lymphoma (ATLL). Leuk Res 20: 357–363.
Letarte, M., Greaves, A. & Ishii, E. (1997). Cell Surface Peptidases in Health and Disease. In The biological functions of CD10/endopeptidase 24.11 in normal and malignant cells, Kenny AJ and Boustead CM (eds), pp. 329–1337, Bios Ltd: Oxford
Nakao, H., Eguchi, K., Kawakami, A. & Nagataki, S. (1989). Increment of Ta1 positive cells in peripheral blood from patients with rheumatoid arthritis. J Rheumat 16: 7–10.
Schön, E., Jahn, S., Kiessig, T., Demuth, H. U., Neubert, K., Barth, A., Von Baehr, R. & Ansörge, S. (1987). The role of dipeptidylpeptidase IV in human T lymphocyte activation: inhibitors and antibodies against dipeptidylpeptidase IV suppress lymphocyte proliferation and immunoglobulin synthesis in vitro. Eur J Immunol 17: 1821–1826.
Scott, C. S., Stark, A. N., Minowada, J. & Drexler, H. G. (1988). Quantitative and qualitative studies of leukemic cell dipeptidyl peptidase II and IV. Leuk Res 12: 129–134.
Srivastava, M. D. & Bhargava, A. K. (1986). Expression of dipeptidylaminopeptidase-IV in some human T and B cell lines. Acta Haematol 76: 25–28.
Tanaka, T., Umeki, K., Yamamoto, Y., Akamoto, F., Noguchi, & Ohtaki, S. (1995). CD26 (dipeptidylpeptidase IV/DPP IV) as a novel molecular marker for differentiated thyroid carcinoma. Int J Cancer 64: 326–331.
Uematsu, T., Urade, M., Yamaoka, M. & Yoshioha, M. (1996). Reduced expression of dipeptidylpeptidase (DPP) IV in peripheral blood T lymphocytes of oral cancer patients. J Oral Pathol Med 25: 507–512.
Vanham, G., Kestens, L., De Meester, I., Vingerhoets, J., Penne, G., Vanhoof, G., Scharpé, S., Heyligen, H., Bosmans, E., Ceuppens, J. L. & Gigase (1993). Decreased expression of the memory marker CD26 on both CD4+ and CD8+ T lymphocytes of HIV-infected subjects. J Acquir Immune Defic Syndr 6: 749–757.
Yokotani, N., Doi, K., Wenthold, J. & Wada, K. (1993). Non-conservation of a catalytic residue in a dipeptidyl aminopeptidase IV-related protein encoded by a gene on human chromosome 7. Hum Mol Genet 2: 1037–1039.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Bauvois, B., Meester, I., Dumont, J. et al. Constitutive expression of CD26/dipeptidylpeptidase IV on peripheral blood B lymphocytes of patients with B chronic lymphocytic leukaemia. Br J Cancer 79, 1042–1048 (1999). https://doi.org/10.1038/sj.bjc.6690167
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690167
Keywords
This article is cited by
-
Depletion of polyfunctional CD26highCD8+ T cells repertoire in chronic lymphocytic leukemia
Experimental Hematology & Oncology (2023)
-
CD26 and Asthma: a Comprehensive Review
Clinical Reviews in Allergy & Immunology (2019)
-
Downregulating CD26/DPPIV by apigenin modulates the interplay between Akt and Snail/Slug signaling to restrain metastasis of lung cancer with multiple EGFR statuses
Journal of Experimental & Clinical Cancer Research (2018)
-
On the origin of serum CD26 and its altered concentration in cancer patients
Cancer Immunology, Immunotherapy (2009)
-
CD26/dipeptidyl peptidase IV enhances expression of topoisomerase II alpha and sensitivity to apoptosis induced by topoisomerase II inhibitors
British Journal of Cancer (2003)